Inovio Pharmaceuticals
INO
INO
186 hedge funds and large institutions have $197M invested in Inovio Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 24 closing their positions.
Holders
186
Holders Change
+3
Holders Change %
+1.64%
% of All Funds
3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
57
Reduced
51
Closed
24
Calls
$2.24M
Puts
$1.89M
Net Calls
+$352K
Net Calls Change
+$498K
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$49.1M |
2 |
2
Millennium Management
New York
|
$6.73M |
3 |
3
BlackRock
New York
|
$36.3M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$26.6M |
5 |
5
D.E. Shaw & Co
New York
|
$13.2M |
Top Sellers
1 |
1
Two Sigma Investments
New York
|
$659K |
2 |
2
Two Sigma Advisers
New York
|
$2.05M |
3 |
3
VOYA Investment Management
Atlanta,
Georgia
|
$145K |
4 |
4
Citigroup
New York
|
$1.84M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$314K |